Skip to main content Accessibility help
×
Home
  • Print publication year: 2019
  • Online publication date: January 2019

Chapter 2 - Genetics of Intellectual Disability

from Section 1 - Understanding Intellectual Disability

Related content

Powered by UNSILO
Amir, R. E. et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics, 23, 185–8. doi: 10.1038/13810
Blau, N., Van Spronsen, F. J. & Levy, H. L. (2010) Phenylketonuria. The Lancet, 376(9750), 1417–27. doi: 10.1016/S0140-6736(10)60961-0
Butler, M. G. (2011) Prader–Willi syndrome: Obesity due to genomic imprinting, Current Genomics, 12(3), 204–15, doi: 10.2174/138920211795677877
Carter, N. (2007) Methods and strategies for analyzing copy number variation using DNA microarrays. Nature Genetics, 39, S16S21. doi: 10.1038/ng2028.Methods
Cassidy, S. B. & Driscoll, D. J. (2009) Prader–Willi syndrome. European Journal of Human Genetics, 17(1), 313. doi: 10.1038/ejhg.2008.165
Cederbaum, S. (2002) Phenylketonuria: An update. Current Opinion in Pediatrics, 14(6), 702–6.
Chahrour, M. & Zoghbi, H. Y. (2007) The story of Rett syndrome: From clinic to neurobiology. Neuron, 56(3), 422–37. doi: 10.1016/j.neuron.2007.10.001
Coe, B. P. et al. (2014) Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nature Genetics, 46(10). doi: 10.1038/ng.3092
Cooper, G. M. et al. (2011) A copy number variation morbidity map of developmental delay. Nature Genetics, 43(9), 838–46. doi: 10.1038/ng.909
Crawford, D. C., Acuña, J. M. & Sherman, S. L. (2001) FMR1 and the fragile X syndrome: human genome epidemiology review. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 3(5), 359–71. doi: 10.1097/00125817-200109000-00006
D’Angelo, D. et al. (2015) Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities. JAMA Psychiatry, 10032, 1. doi: 10.1001/jamapsychiatry.2015.2123
Doherty, J. L. & Owen, M. J. (2014) Genomic insights into the overlap between psychiatric disorders: Implications for research and clinical practice. Genome Medicine, 6(4), 29. doi: 10.1186/gm546
Giaroli, G. et al. (2014) Does rare matter? Copy number variants at 16p11.2 and the risk of psychosis: A systematic review of literature and meta-analysis. Schizophrenia research, 159(2–3), 340–6. doi: 10.1016/j.schres.2014.09.025
Gilissen, C. et al. (2014) Genome sequencing identifies major causes of severe intellectual disability. Nature, 511(7509), 344–7. doi: 10.1038/nature13394
Guy, J. et al. (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science, 315(5815), 1143–7. doi: 10.1126/science.1138389
Habel, A. et al. (2014) Towards a safety net for management of 22q11.2 deletion syndrome: Guidelines for our times. European Journal of Pediatrics, 173(6), 757–65. doi: 10.1007/s00431-013-2240-z
Hooper, S. R. et al. (2013) A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. Research in Developmental Disabilities, 34(5), 1758–69. doi: 10.1016/j.ridd.2012.12.003
Horsler, K. & Oliver, C. (2006) The behavioural phenotype of Angelman syndrome. Journal of Intellectual Disability Research, 50(1), 3353. doi: 10.1111/j.1365-2788.2005.00730.x
Iafrate, A. J. et al. (2004) Detection of large-scale variation in the human genome. Nature Genetics, 36(9), 949–51. doi: 10.1038/ng1416
Jacobs, P. A. & Strong, J. A. (1959) A case of human intersexuality having a possible XXY sex-determining mechanism. Nature, 183(4657), 302–3. Available at: www.ncbi.nlm.nih.gov/pubmed/13632697
Jamuar, S. S. et al. (2014) Somatic mutations in cerebral cortical malformations. New England Journal of Medicine, 371(8), 733–43. doi: 10.1056/NEJMoa1314432
Karmiloff-Smith, A. et al. (2016) The importance of understanding individual differences in Down syndrome. F1000Research, 5, 389. doi: 10.12688/f1000research.7506.1
Khwaja, O. S. et al. (2014) Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America, 111(12), 4596–601. doi: 10.1073/pnas.1311141111
Kirov, G. et al. (2014) The penetrance of copy number variations for schizophrenia and developmental delay. Biological Psychiatry, 75(5), 378–85. doi: 10.1016/j.biopsych.2013.07.022
LaFramboise, T. (2009) Single nucleotide polymorphism arrays: A decade of biological, computational and technological advances. Nucleic Acids Research, 37(13), 4181–93. doi: 10.1093/nar/gkp552
Ledbetter, D. H. et al. (1981) Deletions of chromosome 15 as a cause of the Prader–Willi syndrome. New England Journal of Medicine, 304(6), 325–9. doi: 10.1056/NEJM198102053040604
Lehner, T., Senthil, G. & Addington, A. M. (2014) Convergence of advances in genomics, team science, and repositories as drivers of progress in psychiatric genomics. Biological Psychiatry, 77(1), 614. doi: 10.1016/j.biopsych.2014.01.003
Lejeune, J. et al. (1959) Les chromosomes humains en culture de tissus. Comptes rendus hebdomadaires des séances de l’Académie des sciences, (248), 602–3.
Lejeune, J. et al. (1963) Ségrégation familiale d’une translocation 5–13 déterminant une monosomie et une trisomie partielles du bras court du chromosome 5: Maladie du ‘cri du chat’ et sa ‘réciproque’. Comptes rendus hebdomadaires des séances de l’Académie des sciences, 257, 3098–102. Available at: www.ncbi.nlm.nih.gov/pubmed/14095841
Lubs, H. A., Stevenson, R. E. & Schwartz, C. E. (2012) Fragile X and X-linked intellectual disability: Four decades of discovery. American Journal of Human Genetics, 90(4), 579–90. doi: 10.1016/j.ajhg.2012.02.018
Lynch, M. (2010) Rate, molecular spectrum, and consequences of human mutation. Proceedings of the National Academy of Sciences, 107(3), 961–8. doi: 10.1073/pnas.0912629107
MacDonald, J. R. et al. (2014) The Database of Genomic Variants: A curated collection of structural variation in the human genome. Nucleic Acids Research, 42, D986–92. doi: 10.1093/nar/gkt958
McRae, J. F. et al. (2017) Prevalence and architecture of de novo mutations in developmental disorders. Nature, 542(7642), 433–8. doi: 10.1038/nature21062
Miller, D. T. et al. (2010) Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 86(5), 749–64. doi: 10.1016/j.ajhg.2010.04.006
Monks, S. et al. (2014) Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. Schizophrenia Research, 153(1–3), 231–6. doi: 10.1016/j.schres.2014.01.020
Najmabadi, H. et al. (2011) Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature, 478(7367), 5763. doi: 10.1038/nature10423
Neul, J. L. & Zoghbi, H. Y. (2004) Rett Syndrome: A prototypical neurodevelopmental disorder. Neuroscientist, 10(2), 118–28. doi: 10.1177/1073858403260995
O’Donovan, M. C. & Owen, M. J. (2016) The implications of the shared genetics of psychiatric disorders. Nature Medicine, 22(11). doi: 10.1038/nm.4196
Ou, Z. et al. (2008) Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 10(4), 267–77. doi: 10.1097/GIM.0b013e31816b64c2
Palmer, E. et al. (2014) Changing interpretation of chromosomal microarray over time in a community cohort with intellectual disability. American Journal of Medical Genetics. Part A, 164A(2), 377–85. doi: 10.1002/ajmg.a.36279
Pelc, K., Cheron, G. & Dan, B. (2008) Behavior and neuropsychiatry manifestations in Angelman syndrome. Neuropsychiatric Disease and Treatment, 4(3), 577–84. doi: 10.2147/NDT.S2749
Pieretti, M. et al. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 66(4), 817–22. Available at: www.ncbi.nlm.nih.gov/pubmed/1878973
Portnoï, M. F. (2009) Microduplication 22q11.2: A new chromosomal syndrome. European Journal of Medical Genetics. Elsevier Masson SAS, 52(2–3), 8893. doi: 10.1016/j.ejmg.2009.02.008
Redon, R. et al. (2006) Global variation in copy number in the human genome. Nature, 444(7118), 444–54. doi: 10.1038/nature05329
Rees, E. et al. (2014) Evidence that duplications of 22q11.2 protect against schizophrenia. Molecular Psychiatry, 19(1), 3740. doi: 10.1038/mp.2013.156
Rees, E. et al. (2016) Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry, 73(9), 963–9. doi: 10.1001/jamapsychiatry.2016.1831
Rousseau, F. et al. (2011) The fragile X mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge. Clinical Biochemist. Reviews, 32(3), 135–62. Available at: www.ncbi.nlm.nih.gov/pubmed/21912443
Schneider, M. et al. (2014) Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: Results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. American Journal of Psychiatry, 171(6), 627–39. doi: 10.1176/appi.ajp.2013.13070864
Scriver, C. R. (2007) The PAH gene, phenylketonuria, and a paradigm shift. Human Mutation, 28(9), 831–45. doi: 10.1002/humu.20526
Sebat, J. et al. (2004) Large-scale copy number polymorphism in the human genome. Science, 305(5683), 525–8. doi: 10.1126/science.1098918
Shprintzen, R. J. (2008) Velo-Cardio-Facial Syndrome: 30 years of study. Developmental Disabilities Research Reviews, 14(1), 310. doi: 10.1002/ddrr.2.Velo-Cardio-Facial
Sigafoos, J., O’Reilly, M. F. & Lancioni, G. E. (2009) Cri-du-chat. Developmental Neurorehabilitation, 12(3), 119–21. doi: 10.1080/17518420902975720
Tjio, J. H. & Levan, A. (1956) The chromosome number of man. Hereditas, 42, 16. doi: 10.1111/j.1601-5223.1956.tb03010.x
Van Buggenhout, G. & Fryns, J.-P. (2009) Angelman syndrome (AS, MIM 105830). European Journal of Human Genetics, 17(11), 1367–73. doi: 10.1038/ejhg.2009.67
Verri, A. et al. (2010) Klinefelter’s syndrome and psychoneurologic function. Molecular Human Reproduction, 16(6), 425–33. doi: 10.1093/molehr/gaq018
de Villiers, J. & Porteous, M. (2012) Genetic testing of adults with intellectual disability. Psychiatrist, 36(11), 409–13. doi: 10.1192/pb.bp.111.038216
Visootsak, J. & Graham, J. M. (2006) Klinefelter syndrome and other sex chromosomal aneuploidies. Orphanet Journal of Rare Diseases, 1, 42. doi: 10.1186/1750-1172-1-42
Vissers, L. E. et al. (2010) A de novo paradigm for mental retardation. 42(12), 1109–12. doi: 10.1038/ng.712
Vissers, L. E. L. M., Gilissen, C. & Veltman, J. A. (2015) Genetic studies in intellectual disability and related disorders. Nature Reviews Genetics, 17(1), 918. doi: 10.1038/nrg3999
Weiss, L. A. et al. (2008) Association between microdeletion and microduplication at 16p11.2 and autism. New England Journal of Medicine, 358(7), 667–75. doi: 10.1056/NEJMoa075974
Wiseman, F. K. et al. (2015) A genetic cause of Alzheimer disease: Mechanistic insights from Down syndrome. Nature Reviews Neuroscience, 16(9), 564–74. doi: 10.1038/nrn3983
Wolfe, K., Strydom, A. et al. (2017) Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders. European Journal of Human Genetics: EJHG, 25(1), 6672. doi: 10.1038/ejhg.2016.107
Wolfe, K., Stueber, K. et al. (2017) Genetic testing in intellectual disability psychiatry: Opinions and practices of UK child and intellectual disability psychiatrists. Journal of Applied Research in Intellectual Disabilities, 23, 112. doi: 10.1111/jar.12391
Zufferey, F. et al. (2012) A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. Journal of Medical Genetics, 49(10), 660–8. doi: 10.1136/jmedgenet-2012-101203